MAPK: A Key Player in the Development and Progression of Stroke

Area of Science:

• Neuroscience
• Molecular Biology
• Cellular Signaling

Background:

• Stroke pathogenesis involves complex genetic and environmental factors, with unclear etiological mechanisms hindering effective prevention and treatment.
• The Mitogen-Activated Protein Kinase (MAPK) signaling pathway regulates fundamental cellular processes and is implicated in various diseases.
• Growing evidence suggests MAPK pathway involvement in ischemic stroke pathogenesis and progression.

Purpose of the Study:

• To review the pathological processes of different cell types involved in stroke.
• To discuss the intricate mechanisms of MAPK pathway involvement in stroke.
• To elucidate MAPK signaling molecules as potential therapeutic targets for stroke.

Main Methods:

• Comprehensive literature review on stroke pathology and MAPK signaling.
• Analysis of cellular responses to stroke injury within the brain.
• Synthesis of current knowledge on MAPK pathway's role in ischemic stroke.

Main Results:

• MAPK signaling pathway is intricately linked to the pathogenesis and development of ischemic stroke.
• MAPK molecules exhibit varied responses across different brain cell types post-stroke injury.
• The complexity of MAPK pathway regulation presents challenges in fully elucidating its role.

Conclusions:

• MAPK signaling pathway is a critical player in stroke pathology.
• Targeting MAPK signaling molecules offers a promising therapeutic strategy for stroke prevention and treatment.
• Further research is needed to fully understand the complex mechanisms for optimized therapeutic interventions.